Growth Metrics

Teladoc Health (TDOC) Receivables - Other (2021 - 2025)

Teladoc Health (TDOC) has disclosed Receivables - Other for 6 consecutive years, with $8.8 million as the latest value for Q4 2025.

  • Quarterly Receivables - Other fell 9.94% to $8.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $8.8 million through Dec 2025, down 9.94% year-over-year, with the annual reading at $8.8 million for FY2025, 9.94% down from the prior year.
  • Receivables - Other hit $8.8 million in Q4 2025 for Teladoc Health, up from $8.7 million in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $25.1 million in Q1 2023 to a low of $8.6 million in Q2 2025.
  • Historically, Receivables - Other has averaged $15.4 million across 5 years, with a median of $12.6 million in 2023.
  • Biggest five-year swings in Receivables - Other: grew 18.53% in 2022 and later tumbled 49.62% in 2023.
  • Year by year, Receivables - Other stood at $21.2 million in 2021, then increased by 18.53% to $25.1 million in 2022, then crashed by 49.62% to $12.6 million in 2023, then decreased by 22.4% to $9.8 million in 2024, then decreased by 9.94% to $8.8 million in 2025.
  • Business Quant data shows Receivables - Other for TDOC at $8.8 million in Q4 2025, $8.7 million in Q3 2025, and $8.6 million in Q2 2025.